Biomarin Pharmaceutical Inc financial data

Symbol
BMRN on Nasdaq
Location
105 Digital Drive, Novato, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 528 % +74.5%
Quick Ratio 192 % +69%
Debt-to-equity 24.1 % -27.7%
Return On Equity 8.84 % +42.1%
Return On Assets 7.13 % +52.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192M shares +0.8%
Common Stock, Shares, Outstanding 192M shares +0.81%
Entity Public Float 8.7B USD -13.9%
Common Stock, Value, Issued 192K USD +0.52%
Weighted Average Number of Shares Outstanding, Basic 192M shares +0.84%
Weighted Average Number of Shares Outstanding, Diluted 192M shares -2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.09B USD +12.4%
Cost of Revenue 578M USD -0.71%
Research and Development Expense 903M USD +15.8%
Costs and Expenses 2.48B USD +3.15%
Operating Income (Loss) 615M USD +75.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 679M USD +73.5%
Income Tax Expense (Benefit) 159M USD +130%
Net Income (Loss) Attributable to Parent 520M USD +61.5%
Earnings Per Share, Basic 2 USD/shares +60%
Earnings Per Share, Diluted 2 USD/shares +60.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.25B USD +85.1%
Accounts Receivable, after Allowance for Credit Loss, Current 790M USD +1.64%
Inventory, Net 1.38B USD +17.2%
Other Assets, Current 204M USD +20.7%
Assets, Current 3.85B USD +26.1%
Deferred Income Tax Assets, Net 1.51B USD -1.42%
Property, Plant and Equipment, Net 1.04B USD -0.69%
Operating Lease, Right-of-Use Asset 28.7M USD -32.9%
Intangible Assets, Net (Excluding Goodwill) 233M USD -10.7%
Goodwill 196M USD 0%
Other Assets, Noncurrent 271M USD +35.9%
Assets 7.61B USD +11.1%
Employee-related Liabilities, Current 178M USD -11.2%
Contract with Customer, Liability, Current 1.37M USD -70.4%
Liabilities, Current 798M USD +11.6%
Operating Lease, Liability, Noncurrent 30.5M USD -19.8%
Other Liabilities, Noncurrent 163M USD +27.9%
Liabilities 1.56B USD +8.37%
Accumulated Other Comprehensive Income (Loss), Net of Tax -33.9M USD -830%
Retained Earnings (Accumulated Deficit) 201M USD
Stockholders' Equity Attributable to Parent 6.06B USD +11.9%
Liabilities and Equity 7.61B USD +11.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 174M USD +271%
Net Cash Provided by (Used in) Financing Activities -38.8M USD +9.38%
Net Cash Provided by (Used in) Investing Activities -28.2M USD -98.4%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 192M shares +0.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 106M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25B USD +85.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 126M USD +5.94%
Operating Lease, Liability 37.7M USD -19.2%
Depreciation 46.9M USD +2.63%
Payments to Acquire Property, Plant, and Equipment 16.8M USD -35.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 482M USD +50.3%
Lessee, Operating Lease, Liability, to be Paid 46.8M USD -19.9%
Property, Plant and Equipment, Gross 1.99B USD +3.83%
Operating Lease, Liability, Current 7.23M USD -16.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.91M USD -19.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.12M USD -18.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 28.4M USD +9875%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.05M USD -22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.94M USD -12.9%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD -2.31%
Unrecognized Tax Benefits 325M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.23M USD -11.8%
Amortization of Intangible Assets 24.2M USD -50.5%
Depreciation, Depletion and Amortization 22.1M USD -19.3%
Deferred Tax Assets, Net of Valuation Allowance 1.55B USD -3.94%
Share-based Payment Arrangement, Expense 186M USD -8.85%
Interest Expense 17.2M USD +8.27%